Krka Welcomes ‘Highest Six-Month EBIT In Company’s History’

But Slovenian Firm Anticipates Lower Net Profit Compared To H1 2022

earnings growth
• Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business